{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:40:47Z","timestamp":1777934447160,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>\n                    An important amount of cytotoxic drug may accumulate in the workplace following the breakage of a vial containing an anticancer drug. Thanks to the monthly monitoring of the surface contamination in our compounding unit, a strong increase of cyclophosphamide contamination was highlighted in the storage area following the breakage of the vial, despite application of the emergency procedure. This study presents an analysis of chemical decontamination in the context of massive contamination. Samples were taken on the floor and on the caster of a storage shelf where the vial broke. The residual contamination was measured with a liquid chromatography\u2013mass spectrometry\/mass spectrometry method. An admixture of 10\n                    <jats:sup>\u22122<\/jats:sup>\n                    M sodium dodecyl sulfate and 70% isopropanol (SDS\/IPA 8:2) was selected as the decontamination solution. High amounts of cyclophosphamide were retrieved. The initial contamination on the floor was over 20\u2009ng\/cm\n                    <jats:sup>2<\/jats:sup>\n                    . Three decontaminations with SDS\/IPA were carried out at Day 61, Day 68, and Day 71. The amount of cyclophosphamide decreased to 0.45\u2009ng\/cm\n                    <jats:sup>2<\/jats:sup>\n                    at D134. However, high values were still measured on the caster despite successive decontaminations, with a maximal value of 19.78\u2009ng\/cm\n                    <jats:sup>2<\/jats:sup>\n                    observed at Day 106. Continuous monitoring in our unit led us to highlight the inefficiency of our emergency procedure to eliminate high cyclophosphamide contamination. The procedure involving the SDS\/IPA admixture was more efficient on the floor compared to the caster, which is a different surface type and porosity. This work highlights the importance of improving the procedures of incident management using contamination monitoring and repeated decontamination procedures adapted to different contaminants and surfaces.\n                  <\/jats:p>","DOI":"10.1177\/1078155220915961","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T10:01:28Z","timestamp":1586599288000},"page":"2038-2041","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unit"],"prefix":"10.1177","volume":"26","author":[{"given":"Oph\u00e9lie","family":"Petit","sequence":"first","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Saint-Lorant","sequence":"additional","affiliation":[{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les Formes Injectables et les Technologies Associ\u00e9es, CHU Lille, University of Lille, Lille, France"},{"name":"Department of Pharmacy, CHU de Caen, Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Vasseur","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les Formes Injectables et les Technologies Associ\u00e9es, CHU Lille, University of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Boucher","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Courtin","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Pinturaud","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Allorge","sequence":"additional","affiliation":[{"name":"P\u00f4le de Biologie-Pathologie-G\u00e9n\u00e9tique, Unit\u00e9 Fonctionnelle de Toxicologie, CHU Lille, Lille, France"},{"name":"EA-4483-IMPECS-IMPact de l\u2019Environnement Chimique sur la Sant\u00e9 Humaine, University of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Decaudin","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les Formes Injectables et les Technologies Associ\u00e9es, CHU Lille, University of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-440X","authenticated-orcid":false,"given":"Nicolas","family":"Simon","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les Formes Injectables et les Technologies Associ\u00e9es, CHU Lille, University of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[{"name":"Institut de Pharmacie, CHU Lille, Lille, France"},{"name":"ULR 7365\u2014GRITA\u2014Groupe de Recherche sur les Formes Injectables et les Technologies Associ\u00e9es, CHU Lille, University of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,4,11]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91939-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155207082350"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp180564"},{"key":"e_1_3_2_5_2","unstructured":"National Institute of Occupational Safety and Health. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings www.cdc.gov\/niosh\/docs\/2004-165\/pdfs\/2004-165.pdf (2016 accessed 30 October 2019)."},{"key":"e_1_3_2_6_2","unstructured":"Occupational Safety and Health Administration. Controlling occupational exposure to hazardous drugs www.osha.gov\/SLTC\/hazardousdrugs\/controlling_occex_hazardousdrugs.html (accessed 7 January 2020)."},{"key":"e_1_3_2_7_2","unstructured":"United States Pharmacopeial Convention. USP general chapter <800> hazardous drugs \u2013 handling in healthcare settings www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/healthcare-quality-safety\/generalchapter-800.pdf (2017 accessed 30 October 2019)."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2013-101717.167"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219831427"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201335"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/mev031"},{"key":"e_1_3_2_12_2","unstructured":"International Agency for Research on Cancer. IARC monographs \u2013 classifications https:\/\/monographs.iarc.fr\/list-of-classifications\/ (accessed 30 October 2019)."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.1.68"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/15459624.2015.1009985"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155220915961","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155220915961","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155220915961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:22:52Z","timestamp":1777688572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155220915961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,11]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1177\/1078155220915961"],"URL":"https:\/\/doi.org\/10.1177\/1078155220915961","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,11]]}}}